Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
The Role of Brain Dopamine in Chronic Pain
- Conditions
- Interventions
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 10
- Registration Number
- NCT05285683
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
- Conditions
- Interventions
- First Posted Date
- 2022-02-16
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Ariel University
- Target Recruit Count
- 30
- Registration Number
- NCT05243186
- Locations
- 🇮🇱
Ariel University, Ariel, Israel
Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Peking University Sixth Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT05229627
Methylphenidate in Childhood Apraxia of Speech
- Conditions
- Interventions
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT05185583
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
- Conditions
- Interventions
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- University of Haifa
- Target Recruit Count
- 53
- Registration Number
- NCT05133804
- Locations
- 🇮🇱
University of Haifa, Haifa, Israel
🇮🇱Lev HaSharon Mental Health Center, Netanya, Israel
🇮🇱Emek Medical Center, Afula, Israel
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 112
- Registration Number
- NCT05041946
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Endocrine Disrupting Chemicals and Hormones in ADHD
- Conditions
- Interventions
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Chang Gung Memorial Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT04970303
- Locations
- 🇨🇳
Liang-Jen Wang, Kaohsiung, Taiwan
FASST - Fetal Alcohol Spectrum Stimulant Trial
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Monash Medical Centre
- Target Recruit Count
- 20
- Registration Number
- NCT04968522
- Locations
- 🇦🇺
Monash Health, Clayton, Victoria, Australia
The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD
- Conditions
- Interventions
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Bambino Gesù Hospital and Research Institute
- Target Recruit Count
- 26
- Registration Number
- NCT04964427
- Locations
- 🇮🇹
Bambino Gesù Hospital and Research Institute, Roma, Italy
Methylphenidate for Ptsd and Stroke Veterans
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 60
- Registration Number
- NCT04885257
- Locations
- 🇺🇸
Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.